Qualio is a purpose-built quality and compliance platform for life sciences companies operating in complex, high-stakes regulatory environments. Medical device, SaMD, biotech, and pharma teams use Qualio to replace fragmented eQMS tools, spreadsheets, and consultant-driven audits with a single, validated system that delivers continuous audit and inspection readiness.
Qualio combines a modern eQMS with Compliance Intelligence—an AI-driven layer that continuously evaluates how well real operating data aligns with regulatory requirements. Instead of treating audits as one-off events, teams gain always-on visibility into compliance coverage, risk exposure, and readiness across FDA, ISO, EU MDR, GxP, and software-intensive standards.
Core quality workflows—document control, training, CAPA, change management, supplier quality, and design controls—are directly connected to regulatory obligations and objective evidence. Deep integrations with Jira, Azure DevOps, GitHub, TestRail, and Salesforce automatically capture proof from development and operational systems, eliminating manual evidence gathering and reducing compliance drag on engineering teams.
Compliance Intelligence runs multi-standard gap analysis in under an hour, flags emerging risks before they become findings or 483s, and maps reusable evidence across frameworks to accelerate submissions and market expansion. All insights are explainable and traceable back to specific clauses and internal policies, supporting validation and audit expectations.
The result: audit readiness in weeks instead of months, fewer fire drills, faster launches, and lower long-term compliance cost. Qualio turns compliance from a reactive burden into a predictable, scalable system.
Learn more
FrameworkLTC's fully integrated and scalable platform automates all manual tasks, allowing LTC pharmacies to focus on what is most important: improving patient lives. Automation replaces manual tasks and allows you to expand your business while maximising margins. Delivering services that meet the needs of each facility will strengthen your partner relationships. Our facility-centric software allows you to provide concierge-level service, catering to every patient, wing, and facility. Allow facilities to print bills, check order statuses, and process returns according to your pre-defined rules. Your facilities will appreciate your reports. Automate refill and reorder prescriptions so they don't get lost on the production floor.
Learn more
Compier Literature Screening
Compier Literature Screening is an AI-powered platform aimed at helping pharmacovigilance experts streamline the process of reviewing abstracts, full texts, and translated articles to uncover pertinent information about patients, authors, events, products, and safety-related data. This innovative platform seamlessly connects with various online biomedical databases, including Medline, and allows users to upload literature records in bulk from multiple sources like Embase, conference presentations, and PDF journals. It conducts automated duplicate checks for every literature search and employs validated AI models for the automatic screening and annotation of key entities. Users have the flexibility to set up scalable literature screening workflows that meet their unique needs and comply with international regulations. The system enhances collaboration with external vendors to secure full texts and comes equipped with translation capabilities. Additionally, it integrates smoothly with safety systems, such as Oracle Argus Safety, to share articles relevant to Individual Case Safety Reports (ICSRs), thereby ensuring comprehensive safety monitoring. The platform ultimately seeks to improve the overall efficiency and accuracy of pharmacovigilance activities.
Learn more
BenevolentAI
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Learn more
